JPH01126557A - Reagent for immunological measurement - Google Patents
Reagent for immunological measurementInfo
- Publication number
- JPH01126557A JPH01126557A JP28310587A JP28310587A JPH01126557A JP H01126557 A JPH01126557 A JP H01126557A JP 28310587 A JP28310587 A JP 28310587A JP 28310587 A JP28310587 A JP 28310587A JP H01126557 A JPH01126557 A JP H01126557A
- Authority
- JP
- Japan
- Prior art keywords
- solid phase
- antibody
- amount
- polylysine
- comparative example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 14
- 238000005259 measurement Methods 0.000 title description 16
- 230000001900 immune effect Effects 0.000 title 1
- 239000007790 solid phase Substances 0.000 claims abstract description 35
- 108010039918 Polylysine Proteins 0.000 claims abstract description 13
- 229920000656 polylysine Polymers 0.000 claims abstract description 13
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000013078 crystal Substances 0.000 claims abstract description 10
- 239000000427 antigen Substances 0.000 claims abstract description 8
- 102000036639 antigens Human genes 0.000 claims abstract description 8
- 108091007433 antigens Proteins 0.000 claims abstract description 8
- 238000003018 immunoassay Methods 0.000 claims description 14
- 229940027941 immunoglobulin g Drugs 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 17
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 238000004132 cross linking Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 21
- 238000010586 diagram Methods 0.000 description 20
- 239000004793 Polystyrene Substances 0.000 description 16
- 229920002223 polystyrene Polymers 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- SVOAXTTVWPHOQW-UHFFFAOYSA-N 2-acetylsulfanylbutanedioic acid Chemical compound CC(=O)SC(C(O)=O)CC(O)=O SVOAXTTVWPHOQW-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 238000003452 antibody preparation method Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- -1 Potassium ferricyanide Chemical compound 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000002494 anti-cea effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
【発明の詳細な説明】
A産業上の利用分野
本発明は、固相を用いた免疫測定試薬であり、固相にア
ルミナ単結晶(Al□03)を使い、ポリリジン層とグ
ルタルアルデヒド層と抗体または抗原層を順次形成して
、固相への抗体結合量及び抗体結合力を増加させ、測定
範囲の拡大、検出限界の感度の上昇、及び再現性の向上
を得た免疫測定試薬に関するものである。Detailed Description of the Invention A. Industrial Field of Application The present invention is an immunoassay reagent using a solid phase, in which alumina single crystal (Al□03) is used as the solid phase, and a polylysine layer, a glutaraldehyde layer, and an antibody are used. Or, it relates to an immunoassay reagent that sequentially forms antigen layers to increase the amount of antibody binding to the solid phase and the antibody binding strength, thereby expanding the measurement range, increasing the sensitivity of the detection limit, and improving reproducibility. be.
B発明の概要
本発明は、アルミナ単結晶(A+*OS)を固相として
、その固相上に、ポリリジン層とグルタルアルデヒド層
と抗体または抗原層を順次形成したことからなる免疫測
定試薬に関するものである。B. Summary of the Invention The present invention relates to an immunoassay reagent comprising an alumina single crystal (A+*OS) as a solid phase, on which a polylysine layer, a glutaraldehyde layer, and an antibody or antigen layer are sequentially formed. It is.
C従来の技術
固相を用いる免疫学的測定法には、大きく分けて、競合
法と非競合法に分類される。前者の代表例は、第1抗体
固相法、後者は、サンドイッチ測定法がある。C. Conventional Technology Immunoassay methods using solid phases are broadly classified into competitive methods and non-competitive methods. A representative example of the former is the first antibody solid phase method, and the latter is the sandwich measurement method.
このサンドイツチ法は、固相に抗体を吸着させ、そこに
抗原をトラップさせる。次に酵素標識抗体をその抗原に
結合させ、結合した酵素標識抗体量から抗原の量を測定
する方法である。In this sandwich method, antibodies are adsorbed onto a solid phase and antigens are trapped there. Next, an enzyme-labeled antibody is bound to the antigen, and the amount of the antigen is measured from the amount of bound enzyme-labeled antibody.
上記の原理のため、サンドイツチ法の検出感度を上昇さ
せるためには、固相への抗体結合量及び抗体結合力が、
大きく影響してくる。Due to the above principle, in order to increase the detection sensitivity of the sandwich method, the amount of antibody bound to the solid phase and the antibody binding strength must be
It will have a big impact.
従来、固相の材料としてはポリスチレン、ガラス、アク
リルニ1〜リルーブクジエンースチレン共重合樹脂(略
してABS)などが多く用いられた。Conventionally, polystyrene, glass, acrylonitrile-lilue-book-diene-styrene copolymer resin (abbreviated as ABS), and the like have often been used as materials for the solid phase.
これらの固相への抗体結合方法は、多くは物理的に吸着
させる方法であった。しかし、この方法では、固相の抗
体結合量が少ない、固相の抗体結合力が弱い、測定値の
バラツキが大きい、非特異的吸着が大きいなどの問題点
があった。Most of the methods for binding antibodies to these solid phases involve physical adsorption. However, this method has problems such as a small amount of antibody bound to the solid phase, weak antibody binding strength of the solid phase, large variations in measured values, and large nonspecific adsorption.
以前、特願昭60−45742で本発明者らが出願した
「免疫学的な測定試薬の調整法とこれによって得た試薬
」では、上記の問題点を解決するために、固相をアミノ
酸処理した後、二官能性アルデヒド処理し、抗体結合さ
せたものであり、その効果は上記問題点を解決するに至
った。Previously, in the patent application No. 60-45742 entitled "Method for preparing immunological assay reagents and reagents obtained thereby," the solid phase was treated with amino acids in order to solve the above problems. After that, it was treated with a bifunctional aldehyde and bound to an antibody, which has the effect of solving the above problems.
D発明が解決しようとする問題点
しかし、免疫測定試薬としての検出限界、測定範囲及び
再現性のより一層の向上が望まれていた。D Problems to be Solved by the Invention However, it has been desired to further improve the detection limit, measurement range, and reproducibility as an immunoassay reagent.
本発明は、かかる問題点を解決するためになされたもの
で、固相の抗体結合量が多く、固相の抗体結合力も強く
、測定値のバラツキが小さい、非特異的吸着の少ない免
疫測定試薬を得ることはもちろんの事として、免疫測定
試薬としての測定範囲の拡大、検出限界の感度上昇及び
再現性のより一層の向上を成し得た免疫測定試薬を得る
ことを目的とする。The present invention has been made to solve these problems, and is an immunoassay reagent that has a large amount of antibody binding on the solid phase, strong antibody binding force on the solid phase, small variation in measured values, and low nonspecific adsorption. The object of the present invention is, of course, to obtain an immunoassay reagent that can expand the measurement range, increase the sensitivity of the detection limit, and further improve reproducibility.
E問題点を解決するための手段
この発明に係わる免疫測定試薬では、ポリリジン層とグ
ルグルアルデヒド層と抗体または抗原層を順次形成した
、生体親和性の高いアルミナ単結晶(A l x O3
)を使い、そのアルミナ単結晶(人1zoi)を固相と
したものである。Means for Solving Problem E The immunoassay reagent according to the present invention uses alumina single crystal (A
), and its alumina single crystal (1 zoi) is used as the solid phase.
F作用
生体親和性の高いアルミナ単結晶(人1□03)を固相
に使うことにより、固相とポリリジンの結合力と結合量
が増加する。それにより、架橋するグルタルアルデヒド
量が増加し、抗体結合量及び抗体結合力が増加する。F action By using alumina single crystal (Human 1□03) with high biocompatibility as the solid phase, the binding strength and amount of binding between the solid phase and polylysine are increased. As a result, the amount of crosslinking glutaraldehyde increases, and the amount of antibody binding and antibody binding strength increase.
G実施例
(11”’ic E A (ガン胎児性抗原)を用いた
抗体結合量の評価
実施例1゜
第1図は本発明の一実施例を示す免疫測定試薬の調整方
法図である。Example G (Evaluation of antibody binding amount using 11"'ic EA (carcinoembryonic antigen) Example 1) FIG. 1 is a diagram showing a method for preparing an immunoassay reagent according to an embodiment of the present invention.
調整方法は、アルミナ単結晶(A+zO3) (息下、
A1.sボールと略す)をAl(0,1mg/−ポリリ
ジンを含む0.15mol/ lホウ酸緩衝液(pH8
,5) )中に室温で、1晩浸漬してポリリジン処理を
行った。The adjustment method is alumina single crystal (A+zO3) (under breath,
A1. s-ball) was mixed with Al (0.15 mol/l borate buffer (pH 8) containing 0.1 mg/- polylysine.
, 5) ) at room temperature overnight for polylysine treatment.
蒸留水で洗浄し、5%グルタルアルデヒド水溶液ニ、3
0℃で2時間浸漬してグルクルアルデヒド処理を行った
。蒸留水で洗浄し、B液(Q、ll11g/mi免疫グ
ロブリンG(IgGと略す)、0.1mol/ lリン
酸緩衝液(PH7,s) ) 4℃で1晩浸漬した。さ
らにB液で洗浄した後、C液(0,O1mol/ j
リン酸緩衝液(p[(7,0)、0.1mol/j N
a1l、0.1*牛血清アルブミン(B S Aと略す
)、0.1XNaNs ffl、合液)で洗浄した後、
C液に浸漬し、4℃で保存した。Wash with distilled water and add 5% glutaraldehyde aqueous solution.
Gluculaldehyde treatment was performed by immersing at 0°C for 2 hours. It was washed with distilled water and immersed in solution B (Q, 111 g/mi immunoglobulin G (abbreviated as IgG), 0.1 mol/l phosphate buffer (PH7, s)) at 4°C overnight. After further washing with liquid B, liquid C (0,01 mol/j
Phosphate buffer (p[(7,0), 0.1 mol/j N
After washing with a1l, 0.1*bovine serum albumin (abbreviated as BSA), 0.1X NaNs ffl, combined solution),
It was immersed in Solution C and stored at 4°C.
本実施例では、IgGを抗ガン胎児性抗原(抗CEAと
略す)−IgGとして被覆AI、sボールを調整した。In this example, coated AI and s-ball were prepared using anti-carcinoembryonic antigen (abbreviated as anti-CEA)-IgG as IgG.
第2図は競合反応による抗体結き量の測定操作図であり
、第1図の方法で調整された抗CEA−IgG被覆A1
.sボールを1”■−〇 E A溶液(約2X10’C
pm[カウントバー・ミニフッ])100μ I 、
CEA溶液(0〜11000n/mt’)100μl
SC液100μlの混合溶液で1晩反応させ、洗浄後
、γ−ウェルカウンターで計測した。Figure 2 is a diagram showing the procedure for measuring the amount of antibody bound by competitive reaction, and shows the anti-CEA-IgG coated A1 prepared by the method shown in Figure 1.
.. s-ball in 1”■-〇 E A solution (approximately 2X10'C
pm [count bar/mini foot]) 100μ I,
CEA solution (0-11000n/mt') 100μl
The reaction was carried out overnight with a mixed solution of 100 μl of SC solution, and after washing, measurement was performed using a γ-well counter.
第1図で調整した抗CEA−IgG被覆At、sボール
を第2図の通り、”’Ic E Aにより、抗体結合量
を測定した。結果は、第3図に示す。The amount of antibody bound to the anti-CEA-IgG-coated At and S balls prepared in FIG. 1 was measured by Ic EA as shown in FIG. 2. The results are shown in FIG. 3.
比較例1゜
第1図と同様の方法で、抗CEA−IgG被覆ポリスチ
レンボールを調整し、第2図と同様の方法で、抗体結合
量を測定した。Comparative Example 1 An anti-CEA-IgG coated polystyrene ball was prepared in the same manner as in FIG. 1, and the amount of antibody bound was measured in the same manner as in FIG.
結果は、第3図に示す。The results are shown in Figure 3.
第3図は、実施例1と比較例1の結果であり、A1.s
ボールとポリスチレンボールの抗体結合量変化図である
。図において(a)は実施例1、(b)は比較例1の結
果を示している。FIG. 3 shows the results of Example 1 and Comparative Example 1, and A1. s
It is a diagram showing changes in the amount of antibody binding between balls and polystyrene balls. In the figure, (a) shows the results of Example 1, and (b) shows the results of Comparative Example 1.
図より、抗体結合量はAI、sボールの方がポリスチレ
ンボールより相対的に大であることが判明した。From the figure, it was found that the amount of antibody bound to AI and s balls was relatively larger than that of polystyrene balls.
これは、AI、sがポリスチレンに比べて生体親和性が
強いためである。This is because AI,s has stronger biocompatibility than polystyrene.
(2)酵素標識抗体の固相への非特異的吸着の評価実施
例2゜
第4図は酵素免疫測定(Enzyme Immuno
人5sayEIAと略す)を行う時のIgG−COD(
グルコースオキシダーゼ)標識抗体調整方法図であり、
第5図は非特異的吸着の評価方法の操作図である。(2) Evaluation Example 2 of non-specific adsorption of enzyme-labeled antibodies to solid phase Figure 4 shows enzyme immunoassay (Enzyme Immunoassay).
IgG-COD (abbreviated as EIA)
(glucose oxidase) labeled antibody preparation method diagram,
FIG. 5 is an operational diagram of the method for evaluating non-specific adsorption.
IgG−COD標識抗体調整方法は、まずCOD約3m
g70.3mNを4倍量のO,1mol/ lリン酸緩
衝ン戊(PH7,0) lこ溶かし、GOD: GMB
S(ザクシンイミジル−4−マレイミドブチレイ1−)
=1:5Gの比で添加し、それをO,1mol/ lリ
ン酸l!衛液(pl(6,0)で平衡化したセファデッ
クスG 25 (1x30カラム)を用いて12nJ/
hrで脱塩し、1rnlずつ分取し、マレイミドCOD
を得た。次に、IgGに2m&’の0.1mol/j’
リン酸緩衝’75 (p[[6,o) 5mmol
/ l EDT人を加又、S−アセチルメルカプトこは
く酸を(S−アセチルメルカプトこはく酸: IgG
=300: 1の比で)ジメチルフォルマイトに溶解
し添加する。室温で30分間攪拌後、0.1mol/#
I・リス−塩酸(p[H,O) 0.1−10.1m
ol/1EDTA(pH7,0)0.02m1.1 m
ol// ヒドロキシジアミン水溶液(pli7. O
) 0.1+njを各々加え、30℃4分間反応させた
。D液で平衡化したセファデックスG 25 (1x3
0カラム)を用いて、12mN/hrの速度て脱塩し、
1 meずつ分取し、水冷中コロジオンバッグで濃縮し
、SH−1gGJe得た。得られたマレイミドCODと
SH−IgGを等モル混和し、30℃1時間静置後、4
℃で1晩静置した。0.1mol/eリン酸緩衝液(p
HG、5)、5 mmol/ l EDT人で平衡化し
たセファクリル300 (1x90カラム)に、6mt
’/hrで上記試料を溶出し、1−ずつ分取し、IgG
−COD標識抗体を得た。これを0.1%Nap、、0
.1%BSAとなるように添加し、4℃で保存する。The IgG-COD labeled antibody preparation method first begins with a COD of approximately 3m.
Dissolve g70.3mN in 4 times the volume of O, 1mol/l phosphate buffer (PH7,0), GOD: GMB
S (succinimidyl-4-maleimidobutyrei-1-)
= 1:5G ratio and mixed it with O, 1 mol/l phosphoric acid l! using Sephadex G 25 (1x30 column) equilibrated with saline solution (pl(6,0)) at 12 nJ/
Desalt for 1 hr, separate 1 rnl aliquot, maleimide COD
I got it. Next, add 0.1mol/j' of 2m&' to IgG.
Phosphate buffer '75 (p[[6,o) 5mmol
/ l EDT, S-acetylmercaptosuccinic acid (S-acetylmercaptosuccinic acid: IgG
= 300: 1 ratio) in dimethylformite and added. After stirring at room temperature for 30 minutes, 0.1 mol/#
I.Lis-hydrochloric acid (p[H,O) 0.1-10.1m
ol/1 EDTA (pH 7,0) 0.02 ml 1.1 m
ol// Hydroxydiamine aqueous solution (pli7. O
) 0.1+nj were added to each and reacted at 30°C for 4 minutes. Sephadex G 25 (1x3
0 column) at a rate of 12 mN/hr,
1 me portion was collected and concentrated in a collodion bag while cooling with water to obtain SH-1gGJe. The obtained maleimide COD and SH-IgG were mixed in equimolar amounts, and after standing at 30°C for 1 hour, 4
The mixture was allowed to stand overnight at ℃. 0.1 mol/e phosphate buffer (p
HG, 5), 6 mt in Sephacryl 300 (1x90 column) equilibrated with 5 mmol/l EDT
Elute the above sample at a rate of
-COD labeled antibody was obtained. This is 0.1% Nap,,0
.. Add 1% BSA and store at 4°C.
非特異的吸着は、第5図に示すように、第1図で得られ
た抗CEA−IgG被覆・A1.sボールを、C液で希
釈した抗CEA−IgG−GOD標識抗体0.1−とC
液0.2mlに室温で1晩静置し、蒸留水で洗浄後、0
.5moI/Iグルコース、O,O1mol/ l酢酸
緩衝液(pH’5.1) 0.3mjを加え、37℃2
時間静置した。As shown in FIG. 5, non-specific adsorption was observed in the anti-CEA-IgG coated A1. s ball was mixed with anti-CEA-IgG-GOD labeled antibody 0.1- diluted in C solution and C
Leave to stand overnight at room temperature in 0.2 ml of solution, wash with distilled water, and remove
.. Add 5 mol/I glucose, 0.3 mj of O, 1 mol/l acetate buffer (pH'5.1), and heat at 37°C.
Let it stand for a while.
0.1r+t’サンプリングし、2X1G−’+ol/
J’ルミノール、0、2mol/ (l炭酸緩衝液(p
H9,8)0.5mj、6X10−’IIIo l /
lフェリシアン化カリ水溶w10.5+nl!を各添加
し、15秒待ち、16〜45秒間の発光量を算出する乙
とによって求めた。0.1r+t' sampled, 2X1G-'+ol/
J'luminol, 0.2 mol/(l carbonate buffer (p
H9,8) 0.5mj, 6X10-'IIIol/
l Potassium ferricyanide water soluble w10.5+nl! was added, waited 15 seconds, and calculated the amount of luminescence for 16 to 45 seconds.
比較例2゜
第1図と同様に調整した抗CE A’−I gG被覆ポ
リスチレンボールを用いて、第5図の様にポリスチレン
ボールの非特異的吸着量を求めた。Comparative Example 2 Using anti-CE A'-IgG coated polystyrene balls prepared in the same manner as in FIG. 1, the amount of non-specific adsorption of the polystyrene balls was determined as shown in FIG.
実施例2と比較例2で、酵素標識抗体の固相への非特異
的吸着を比較した。なお、評価法は、添加IgG−GO
D標識抗体に対するIgG−COD標識抗体の固相への
吸着量の割合(%)とした。結果を表1に示す。In Example 2 and Comparative Example 2, nonspecific adsorption of an enzyme-labeled antibody to a solid phase was compared. In addition, the evaluation method is based on added IgG-GO
It was expressed as the ratio (%) of the amount of IgG-COD labeled antibody adsorbed on the solid phase to the D labeled antibody. The results are shown in Table 1.
表IA1.sボールとポリスチレンボールサンドイッチ
測定法の感度を左右する主な要因の1つである酵素標識
抗体の固相への非特異的吸着ば両者に差がないという結
果を得た。これは抗体を固相へ吸着後、牛血清アルブミ
ンによるブロックがA1.sの場合でも、ポリスチレン
と同程度に有効であるためである。Table IA1. The results showed that there was no difference between the S-ball and polystyrene ball sandwich assays in terms of non-specific adsorption of the enzyme-labeled antibody to the solid phase, which is one of the main factors influencing the sensitivity of the two methods. This is because after adsorbing the antibody to the solid phase, blocking with bovine serum albumin is A1. This is because even in the case of s, it is as effective as polystyrene.
(3)検出限界、測定範囲の評価 第6図は測定範囲および検出限界の比較操作図である。(3) Evaluation of detection limit and measurement range FIG. 6 is a comparison diagram of measurement range and detection limit.
以下にその操作を示す。第1図の操作で得られた抗CE
A−IgG被覆A1.sボールおよび抗CEA−IgG
被覆ポリスチレンボールをCEA標準1々(C液で希釈
)0.1−とC液0.2ml’に室温で6時間静置し、
蒸留水で洗浄後、C液で希釈した抗CEA−IgG−G
OD標識抗体0.1mt’とC液0.2mlに室渇で1
晩静置し、蒸留水で洗浄後、0.5mo 171グルコ
ース、0.01mol/l酢酸緩衝液(p[5,1)
0.3mjを加え、37℃2時間静置した。0.1−サ
ンプリングし、2X10−’+ol/ lルミノール、
0.2mol/l’炭酸緩衝液(pH9,8)O,Sm
J’、 8X10−”mol/J 7 エリシアン化カ
リ水溶液0.5mjを各添加し、15秒待ち、16〜4
5秒間の発光量を算出する。The operation is shown below. Anti-CE obtained by the procedure shown in Figure 1
A-IgG coating A1. s ball and anti-CEA-IgG
The coated polystyrene balls were placed in 0.1-ml of CEA standard (diluted with liquid C) and 0.2 ml of liquid C for 6 hours at room temperature.
Anti-CEA-IgG-G diluted with solution C after washing with distilled water
Add 0.1 mt' of OD-labeled antibody and 0.2 ml of C solution at room temperature.
After leaving to stand overnight and washing with distilled water, add 0.5 mo 171 glucose, 0.01 mol/l acetate buffer (p[5,1)
0.3 mj was added and left at 37° C. for 2 hours. 0.1-sampled, 2X10-'+ol/l luminol,
0.2 mol/l' carbonate buffer (pH 9,8) O, Sm
J', 8 x 10-''mol/J 7 Add 0.5 mj of potassium elycyanide aqueous solution, wait 15 seconds, 16-4
Calculate the amount of light emitted for 5 seconds.
実施例2と比較例2について検出限界および測定範囲を
比較した。第7図は、その結果であり、CEA濃度−発
光量変化図である。図において、(e)は実施例2、(
d)は比較例2の結果を示している。The detection limits and measurement ranges of Example 2 and Comparative Example 2 were compared. FIG. 7 shows the results and is a CEA concentration-emission amount change diagram. In the figure, (e) is Example 2, (
d) shows the results of Comparative Example 2.
図よりA1.sの方が、ポリスチレンよりCEAの検出
限界、測定範囲いずれも優れていることが判明した。From the figure A1. It was found that s was superior to polystyrene in both the detection limit and measurement range of CEA.
これは、A1.sの抗体結合量が、大であることと、固
相への抗体結合の際、抗体の免疫活性が失われにくいこ
との2点が挙げられる。また、AI、sとポリスチレン
の測定上限が同値なのは、添加した酵素標識抗体量が制
限因子になっているためと考える。This is A1. Two points are mentioned: the amount of antibody bound by s is large, and the immune activity of the antibody is not easily lost when the antibody is bound to the solid phase. Furthermore, the reason that the measurement upper limits of AI,s and polystyrene are the same is considered to be because the amount of enzyme-labeled antibody added is a limiting factor.
(4)検出限界における再現性の評価
実施例2と比較例2で検出限界における口内変動と日間
変動を比較した。結果を表2に示す。(4) Evaluation of reproducibility in detection limit Example 2 and Comparative Example 2 were compared for intraoral variation and daily variation in detection limit. The results are shown in Table 2.
表2A1.sボールとポリスチレンボール日内変動 測
定回数n = 8
日間変動 測定回数n=6
表中()は、CEA濃度を示す。Table 2A1. S ball and polystyrene ball diurnal variation Number of measurements n = 8 Daily variation Number of measurements n = 6 In the table, () indicates the CEA concentration.
検出限界でのA1.Sボールの再現性が、ポリスチレン
ボールよりも優れている。これは、AI。A1 at the detection limit. The reproducibility of S balls is better than that of polystyrene balls. This is AI.
Sボールの抗体結合量が多く、比較する固相の個体差が
、ポリスチレンボールよりも小さいためである。This is because the amount of antibody bound to the S ball is large, and the individual differences in the solid phase to be compared are smaller than that of the polystyrene ball.
(5)固相の抗体結合調整法の評価 比較例3゜ 第8図は、比較例3を示す操作方法図である。(5) Evaluation of solid phase antibody binding adjustment method Comparative example 3゜ FIG. 8 is an operating method diagram showing Comparative Example 3.
調整方法は、B液に4℃で1晩浸漬し、さらにB液で洗
浄した後、C液で3回洗浄した後、C液に浸漬し、4℃
で保存する。The adjustment method is to soak in liquid B overnight at 4°C, wash with liquid B, wash three times with liquid C, then soak in liquid C at 4°C.
Save with .
比較例4゜ 第9図は、比較例4を示す操作方法図である。Comparative example 4゜ FIG. 9 is an operation method diagram showing Comparative Example 4.
調整方法は、A1.gボールをA液中に室温で、1晩浸
漬してポリリジン処理を行った。蒸留水で洗浄し、B液
で4℃で1晩浸漬した。さらにB液で洗浄した後、C液
で3回洗浄した後、Cwlに浸漬し、4℃で保存する。The adjustment method is A1. The g-ball was immersed in liquid A at room temperature overnight to perform polylysine treatment. It was washed with distilled water and immersed in solution B at 4°C overnight. After further washing with solution B and three times with solution C, it is immersed in Cwl and stored at 4°C.
比較例5゜ 第10図は、比較例5を示す操作方法図である。Comparative example 5゜ FIG. 10 is an operation method diagram showing Comparative Example 5.
Fl整方法は、AI、Sボールを5%グルタルアルデヒ
ド水溶液に、30℃で2時間浸漬してグルタルアルデヒ
ド処理を行った。蒸留水で洗浄し、BwR4℃で1晩浸
漬した。さらにB液で洗浄した後、C液で3回洗浄した
後、C液に浸漬し、4℃で保存する。In the Fl preparation method, AI and S balls were immersed in a 5% glutaraldehyde aqueous solution at 30° C. for 2 hours to perform glutaraldehyde treatment. It was washed with distilled water and soaked overnight at BwR 4°C. Further, after washing with B solution and three times with C solution, it is immersed in C solution and stored at 4°C.
実施例2と比較例3,4,5について測定範囲及び検出
限界を第6図の方法で比較した。第11図はその結果で
、処理条件の比較図である。The measurement range and detection limit of Example 2 and Comparative Examples 3, 4, and 5 were compared using the method shown in FIG. FIG. 11 shows the results and is a comparison diagram of the processing conditions.
図において、(e)は比較例3、(f)は比較例4、(
に)は比較例5の結果を示している。In the figure, (e) is Comparative Example 3, (f) is Comparative Example 4, (
) shows the results of Comparative Example 5.
図より、第1図の方法で、WMしたA1.sの方がCE
Aの検出限界及び測定範囲のいずれにおいても優れてい
ることが判明した。From the figure, A1. s is more CE
It was found that A was excellent in both the detection limit and measurement range.
第1図の調整法はボールをポリリジンで被覆後、グルタ
ルアルデヒドで架橋されるため、固相が安定する。この
様な安定した固相に結合した抗体により、抗体結合量及
び抗体結合力が増加しな。In the preparation method shown in FIG. 1, the ball is coated with polylysine and then crosslinked with glutaraldehyde, so that the solid phase is stabilized. The antibody bound to such a stable solid phase increases the amount of antibody bound and the antibody binding strength.
今回は抗体量を検出するための標識物を酵素(COD)
の場合のみ記したが、酵素のみならず蛍光発光物質、放
射性同位元素でも同様な結果を得ている。以下に標識物
の例を示す。酵素(グルコースオキシダーゼ、西洋ワサ
ビペルオキシダーゼ、β−D−ガラクトシグーゼ、グル
コース6リン酸、脱水素酵ズ、アルカリホスファターゼ
等)、発光[t (フルオレセインイソチオシアネ−1
・、テトラメチルローダミンイソチオシアネート等)、
化学発光物質(アミノエチルエチルイソルミノール、ア
ミノブチルエチルイソルミノール、アミノペンチルエチ
ルイソルミノール、アミノヘキシルエチルイソルミノー
ル等)、放射性同位光?(’H。This time, we will use an enzyme (COD) as a label to detect the amount of antibodies.
Although only the case is described, similar results have been obtained not only with enzymes but also with fluorescent substances and radioactive isotopes. Examples of labeled objects are shown below. Enzymes (glucose oxidase, horseradish peroxidase, β-D-galactosigase, glucose 6-phosphate, dehydrogenase, alkaline phosphatase, etc.), luminescence [t (fluorescein isothiocyane-1)
・, tetramethylrhodamine isothiocyanate, etc.),
Chemiluminescent substances (aminoethylethylisoluminol, aminobutylethylisoluminol, aminopentylethylisoluminol, aminohexylethylisoluminol, etc.), radioisotope light? ('H.
目C,32P、 12’I 、””I等)H発明の効果
ポリリジン層とグルクルアルデヒド層と抗体または抗原
層を順次形成した、生体親和性の高いアルミナ単結晶(
Altos)を固相としたので、ポリリジンの被覆量が
上昇し、グルタルアルデヒド処理によって、ポリリジン
の一部のアミノ基が互いにグルタルアルデヒドで、架橋
されるため固相が安定する。この様な安定しな固相に結
合した抗体により、抗体結合量及び抗体結合力が増加す
る。C, 32P, 12'I, ""I, etc.) H Effects of the invention Highly biocompatible alumina single crystal (
Since the polylysine (Altos) was used as a solid phase, the amount of polylysine covered increased, and by the glutaraldehyde treatment, some amino groups of the polylysine were crosslinked with each other with glutaraldehyde, thereby stabilizing the solid phase. Antibody bound to such a stable solid phase increases the amount of antibody bound and the antibody binding strength.
そのため、従来よりも測定範囲が拡大し、検出限界が上
昇し、再現性が向上するという効果がある。Therefore, the measurement range is expanded, the detection limit is increased, and the reproducibility is improved compared to the conventional method.
第1図は本発明の一実施例を示す免疫測定試薬の調整方
法図、第2図は競合反応による抗体結合量の測定操作図
、第3図はA1.sボールとポリスチレンボールの抗体
結合量変化図、第4図は■gG−GOD標識抗体Fl整
方法図、第5図は非特異的吸着の評価方法の操作図、第
6図は測定範囲および検出限界の比較操作図、第7図は
CEA濃度−発光量変化図、第8図は比較例3を示す操
作方法図、第9図は比較例4を示す操作方法図、第1θ
図は比較例5を示す操作方法図、第11図はその結果で
、処理条件の比較図である。FIG. 1 is a diagram of a method for preparing an immunoassay reagent showing an embodiment of the present invention, FIG. 2 is a diagram of a procedure for measuring the amount of antibody bound by competitive reaction, and FIG. 3 is a diagram of A1. Figure 4 shows the change in antibody binding amount between s-ball and polystyrene ball. Figure 4 shows how to prepare gG-GOD-labeled antibody Fl. Figure 5 shows how to evaluate non-specific adsorption. Figure 6 shows the measurement range and detection. Comparison operation diagram of limits, Figure 7 is a CEA concentration-light emission change diagram, Figure 8 is an operation method diagram showing Comparative Example 3, Figure 9 is an operation method diagram showing Comparative Example 4, 1θ
The figure is an operating method diagram showing Comparative Example 5, and FIG. 11 is a comparison diagram of processing conditions showing the results.
Claims (2)
は抗原層を順次形成したアルミナ単結晶を固相としたこ
とを特徴とする免疫測定用試薬。(1) An immunoassay reagent characterized in that the solid phase is an alumina single crystal in which a polylysine layer, a glutaraldehyde layer, and an antibody or antigen layer are sequentially formed.
Gとしたことを特徴とする特許請求の範囲第1項記載の
免疫測定用試薬。(2) The immunoassay reagent according to claim 1, wherein the antibody is anti-carcinoembryonic antigen-immunoglobulin G.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28310587A JPH01126557A (en) | 1987-11-11 | 1987-11-11 | Reagent for immunological measurement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28310587A JPH01126557A (en) | 1987-11-11 | 1987-11-11 | Reagent for immunological measurement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH01126557A true JPH01126557A (en) | 1989-05-18 |
Family
ID=17661282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28310587A Pending JPH01126557A (en) | 1987-11-11 | 1987-11-11 | Reagent for immunological measurement |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01126557A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0456126U (en) * | 1990-09-20 | 1992-05-14 | ||
| US9938378B2 (en) | 2011-04-20 | 2018-04-10 | Spheritech Ltd | Cross-linked poly-E-lysine non-particulate support |
-
1987
- 1987-11-11 JP JP28310587A patent/JPH01126557A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0456126U (en) * | 1990-09-20 | 1992-05-14 | ||
| US9938378B2 (en) | 2011-04-20 | 2018-04-10 | Spheritech Ltd | Cross-linked poly-E-lysine non-particulate support |
| US10266652B2 (en) | 2011-04-20 | 2019-04-23 | Spheritech Ltd. | Cross-linked poly-E-lysine non-particulate support |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1111346A (en) | Assay of antibodies of double surface reagent in presence of interfering materials | |
| WO2001063283A1 (en) | Method of measuring physiologically active sample substance by using porous filter | |
| CN116413445A (en) | Detection card, kit and detection method for detecting total thyroxine content | |
| WO1999060401A1 (en) | Immunoassay reagents and immunoassay method | |
| JPH01126557A (en) | Reagent for immunological measurement | |
| EP1247096B1 (en) | Method for immobilisation of (an) affinity reagent(s) on a hydrophobic solid phase | |
| JPH01126554A (en) | Reagent for immunological measurement | |
| JPH01126549A (en) | Reagent for immunological measurement | |
| JPH01126551A (en) | Reagent for immunological measurement | |
| JPS58149700A (en) | Composite containing peroxidase, its preparation and reagent | |
| JPH01126553A (en) | Reagent for immunological measurement | |
| JPH01126552A (en) | Reagent for immunological measurement | |
| JPH01126556A (en) | Reagent for immunological measurement | |
| JP2000193666A (en) | Enzyme-immunoassay and reagent using absorbing agent | |
| JPH01126555A (en) | Reagent for immunological measurement | |
| JPH01126550A (en) | Reagent for immunological measurement | |
| JPS583671B2 (en) | Methods of increasing the ability of apoglucose oxidase to bind flavin adenine dinucleotide and its derivatives, homogeneous specific binding assays, homogeneous immunoassays for measuring complexes and ligands in liquid media, Reagents and | |
| CN118937682B (en) | Kit for heparin binding protein detection and preparation method thereof | |
| CN120847391B (en) | Sample diluent, application thereof and kit | |
| EP0249955B1 (en) | Kit for use in sandwich immunoassay | |
| JPH0466871A (en) | High sensitive immunoassay | |
| JPS6140066B2 (en) | ||
| KR960016337B1 (en) | Reagent kit for use in sandwich immunoassay | |
| JP2002202309A (en) | Immunological test method | |
| EP0249983B2 (en) | Reagent kit for use in sandwich immunoassay |